FDA Inspection 1192038 — Hammond & Co, Inc

Hammond & Co, Inc — FEI 3016690411

The FDA completed an inspection of Hammond & Co, Inc on Nov 30, 2022 in Oceanside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 30, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oceanside, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.